NCT03839056 is a clinical trial of IC+PIEB+PCEA high flow in Labor Epidural Analgesia, sponsored by Marian Daras.

Who is sponsoring NCT03839056?

NCT03839056 is sponsored by Marian Daras.

What drugs are being tested in NCT03839056?

Interventions in NCT03839056: IC+PIEB+PCEA high flow, PIEB+PCEA high flow, PIEB+PCEA standar flow.

What condition does NCT03839056 study?

NCT03839056 studies Labor Epidural Analgesia.

Is NCT03839056 still recruiting?

NCT03839056 is currently completed. Last updated 22 July 2020.

Last reviewed 2020-07-22 · How we verify

NCT03839056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparative Study of the Combination of Different Modes of Administration of Local Anesthetics in Labor Analgesia

Completed Last updated 22 July 2020

What this trial tests

trial testing IC+PIEB+PCEA high flow in Labor Epidural Analgesia in 151 participants. Completed in 28 February 2019.

Timeline

2 August 2015

Primary endpoint
28 February 2019

28 February 2019

Quick facts

Lead sponsor	Marian Daras
Status	Completed
Study type	OBSERVATIONAL
Enrollment	151
Start date	2 August 2015
Primary completion	28 February 2019
Estimated completion	28 February 2019
Sites	1 location across Spain

Drugs / interventions tested

IC+PIEB+PCEA high flow
PIEB+PCEA high flow
PIEB+PCEA standar flow

Conditions studied

Labor Epidural Analgesia — all drugs for Labor Epidural Analgesia →

Sponsor

Marian Daras

Who can join

Adults 18 to 45, female only, with Labor Epidural Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators have design an observational study to know the anesthetic consumption in terms of rescue analgesia (Patient Controlled Epidural Analgesia (PCEA) and manual boluses) of the combination of different modes of administration of local anesthetic in the epidural space during labor analgesia offered by the new version of the CADD® infusion pump. Also in this pump the anesthetic can be administered across a system of standard flow (40-250ml/h) or of high flow (40-500ml/h), what according to studies can influence the diffusion epidural of the anesthetic and therefore the level of sensitive blockade.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03839056 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marian Daras
Last refreshed: 22 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03839056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing